Stay updated on Genetic Predictors of Benefit to Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the pembrolizumab study is now displayed, including its terminated status, study design, eligibility criteria, treatment arms, outcomes, locations, results, and study documents.
    Difference
    65%
    Check dated 2026-11-08T15:04:10.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T16:13:18.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, saying agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI) under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T15:18:07.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 Forbidden page; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-18T21:57:38.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.1 instead of v3.7.0. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T21:01:19.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study record at NCT02710396 now displays a 403 Forbidden page, replacing the usual study details. This prevents users from accessing the core content and related study information for that record.
    Difference
    21%
    Check dated 2026-09-20T20:37:54.000Z thumbnail image

Stay in the know with updates to Genetic Predictors of Benefit to Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Genetic Predictors of Benefit to Pembrolizumab Clinical Trial page.